Work

Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

Year: 2023

Type: article

Source: Molecular Neurodegeneration

DOI: 10.1186/s13024-023-00684-7

Authors: Karen Y. He, Ekaterina A. Khramtsova, Alfredo Cabrera-Socorro, Yanfei Zhang, Shuwei Li, Brice A. J. Sarver, Bart Smets, Qingqin S. Li, Louis De Muynck, Antonio R. Parrado, Simon Lovestone, Mary Helen Black

Institutions: Janssen Research & Development (United States), Janssen (Belgium)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,990

Funders: Amgen, AstraZeneca, GlaxoSmithKline, Wellcome Trust, UK Research and Innovation

OpenAlex ID: W4389080501

FWCI: 1.411

Cites: 15

Cited by: 8

Related to: 10